PFSVX
Price
$15.55
Change
-$0.06 (-0.38%)
Updated
Jul 31 closing price
Net Assets
52.08M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

PFSVX vs VSMAX

PFSVX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
PFSVX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PFSVX is a Buy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. PFSVX (52.1M). VSMAX pays higher dividends than PFSVX: VSMAX (1.21) vs PFSVX (0.01). PFSVX was incepted earlier than VSMAX: PFSVX (6 years) vs VSMAX (26 years). PFSVX (1.45) is less costly to investors than VSMAX (0.05). PFSVX is a more actively managed with annual turnover of: 98.36 vs. VSMAX (17.00). VSMAX has a lower initial minimum investment than PFSVX: VSMAX (3000) vs PFSVX (10000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. PFSVX (11.24). VSMAX return over 5 years is better than : 35.11 vs. PFSVX (7.00).
PFSVXVSMAXPFSVX / VSMAX
Total Expense Ratio1.220.052,440%
Annual Report Gross Expense Ratio1.450.052,900%
Fund Existence6 years26 years-
Gain YTD10.91314.58875%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets52.1M189B0%
Annual Yield % from dividends0.011.211%
Returns for 1 year11.2422.5850%
Returns for 3 years5.6343.4213%
Returns for 5 years7.0035.1120%
Returns for 10 yearsN/A155.96-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H